Statistical methods in cardiovascular trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
Hazard ratio
ANCOVA
Cox proportional-hazards model
Non-inferiority trial design
Multiple imputation / missing data
Odds ratio
Log-rank test
t-test
All cardiovascular trials
965 results
- Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142792).
- Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02199795).
- Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): Complete Statistical AnalysisIndependent statistical analysis of Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138124).
- GALACTIC-HFIndependent statistical analysis of GALACTIC-HF, the randomized phase 3 trial of omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, including time-to-event methods, KCCQ analysis, confidence intervals, multiplicity, and safety.
- GAMES-PILOTIndependent statistical analysis of Glyburide Advantage in Malignant Edema and Stroke Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01268683).
- Garlic4Independent statistical analysis of Effect of Aged Garlic Extract on Atherosclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01534910).
- Gas ChallengeIndependent statistical analysis of Human Cerebral Blood Flow Regulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04265053).
- General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA): Complete Statistical AnalysisIndependent statistical analysis of Geniculate Artery Embolization for Knee Pain Secondary to Osteoarthritis (OA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03362957).
- GIANTIndependent statistical analysis of Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control: primary endpoint results, effect estimate with…
- GLEAMIndependent statistical analysis of A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence…
- Glucose Regulation in Acute Stroke Patients (GRASP) Study: Complete Statistical AnalysisIndependent statistical analysis of Glucose Regulation in Acute Stroke Patients (GRASP) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00282867).
- GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): Complete Statistical AnalysisIndependent statistical analysis of GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04706273).
- GRAMSIndependent statistical analysis of Gadobutrol Enhanced MRA of the Renal Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344460).
- GRAVITYIndependent statistical analysis of 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GUIDE-ITIndependent statistical analysis of Guiding Evidence Based Therapy Using Biomarker Intensified Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685840).
- Gut Organoid and Microbiome Interactions in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Gut Organoid and Microbiome Interactions in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04497727).
- H3MIndependent statistical analysis of Healthy Hearts Healthy Minds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03373110).
- HALOIndependent statistical analysis of A Study of CIN-107 in Patients With Uncontrolled Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05137002).
- HALT PKD AIndependent statistical analysis of HALT Progression of Polycystic Kidney Disease Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00283686).
- Handgrip Exercise for Arteriovenous Fistula Maturation: Complete Statistical AnalysisIndependent statistical analysis of Handgrip Exercise for Arteriovenous Fistula Maturation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061008).
- Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: Complete Statistical AnalysisIndependent statistical analysis of Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HD-LIPTIndependent statistical analysis of High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HEAL-LAAIndependent statistical analysis of HEAL-LAA Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05809596).
- Heart Failure Medication Adherence: Complete Statistical AnalysisIndependent statistical analysis of Heart Failure Medication Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03402750).
- HEART-FIDIndependent statistical analysis of Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Helius in Hypertension-I: The UK Hypertension Registry: Complete Statistical AnalysisIndependent statistical analysis of Helius in Hypertension-I: The UK Hypertension Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02553512).
- HEROES-DCBIndependent statistical analysis of Lutonix or Inpact for tHE tReatment Of fEmeropopliteal Stenosis - Drug Coated Balloon: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: Complete Statistical AnalysisIndependent statistical analysis of High Purity Type I Collagen Based Skin Substitute Vs Dehydrated Human Amnion/Chorion Membrane in Treatment of DFUs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00349778).
- HMO Research Network CERT: Acute Myocardial Infarction: Complete Statistical AnalysisIndependent statistical analysis of HMO Research Network CERT: Acute Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00211172).
- Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): Complete Statistical AnalysisIndependent statistical analysis of Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02798471).
- Home Based Daratumumab Administration for Patients With Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Home Based Daratumumab Administration for Patients With Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05511428).
- Home-based Telehealth Stroke Care: A Randomized Trial for Veterans: Complete Statistical AnalysisIndependent statistical analysis of Home-based Telehealth Stroke Care: A Randomized Trial for Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00384748).
- Home-HF: Evaluation of Patients With Heart Failure Using Home Telemonitoring: Complete Statistical AnalysisIndependent statistical analysis of Home-HF: Evaluation of Patients With Heart Failure Using Home Telemonitoring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00312884).
- HOPE-3Independent statistical analysis of HOPE-3, a randomized phase 4 factorial trial evaluating candesartan/HCT and rosuvastatin for prevention in cardiovascular disease and stroke, including its composite endpoints, factorial design, and planned statistical analysis.
- HORIZON-HCMIndependent statistical analysis of A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05414175).
- Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130061).
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HW005Independent statistical analysis of Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609842).
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902538).
- Hydroxychloroquine and Cognitive Function After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Cognitive Function After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03025087).
- HYPERIONIndependent statistical analysis of Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- HyperlinkIndependent statistical analysis of Home Blood Pressure Telemonitoring and Case Management to Control Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00781365).
- HYPEROXIA Responses and ROS: Complete Statistical AnalysisIndependent statistical analysis of HYPEROXIA Responses and ROS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05958303).
- HYVETIndependent statistical analysis of HYVET, the Hypertension in the Very Elderly Trial, including trial design, endpoints, planned methodology, statistical interpretation, limitations, and educational concepts.
- iCLAS™ for Persistent Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of iCLAS™ for Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04061603).
- Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: Complete Statistical AnalysisIndependent statistical analysis of Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…